Gains May Be On The Menu For Carisma Therapeutics Inc (NASDAQ: CARM)
Currently, there are 41.79M common shares owned by the public and among those 21.12M shares have been available to trade. The company’s stock has a 5-day price change of -0.16% and 8.99% over the past three months. CARM shares are trading -56.22% year to date (YTD), with the 12-month market performance up to 7.66% higher. […]
Better Times Ahead For Carisma Therapeutics Inc (NASDAQ: CARM)?
Carisma Therapeutics Inc (CARM) concluded trading on Wednesday at a closing price of $0.60, with 36.57 million shares of worth about $21.94 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -24.48% during that period and on June 11, 2025 the price saw a […]